| Pfizer beantragt U5-Zulassung in den USA |  |
[https://apnews.com/article/covid-vaccine-children-pfizer-07d72ab0b76329d3899c135afd2a93f5]
"In an extraordinary move, the Food and Drug Administration had urged Pfizer and its partner BioNTech to apply earlier than the companies had planned.
The nation's 19 million children under 5 are the only group not yet eligible for vaccination against the coronavirus."
"An open question is how many shots those youngsters will need. Pfizer is testing three shots after two of the extra-low doses turned out to be strong enough for babies but not for preschoolers, and the final data from the study isn't expected until late March.
That means the FDA may consider whether to authorize two shots for now, with potentially a third shot being cleared later if the study supports it."
Die FDA (in etwa die amerikanische EMA) drängt Pfizer dazu, die Zulassung des Impfstoffs für U5-Kinder zu beantragen. Pfizer hat das jetzt getan. Die Forschungen laufen noch weiter, weil die Immunreaktion der 3 bis 5 jährigen noch nicht so stark ist, wie erhofft, anders als bei den 0-2 jährigen.